Remi A. Nout

Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup

Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma

Uterine serous carcinoma

Evaluation of treatment effects in patients with endometrial cancer and <i>POLE</i> mutations: An individual patient data meta‐analysis

Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer

Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis

Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study

Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer

Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study

Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging – An analysis from the EMBRACE study

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

Interpretation of somatic <i>POLE</i> mutations in endometrial carcinoma

Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer

L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K–AKT, Wnt/β-catenin and P53 pathway activation

Do clinicians and patients agree regarding symptoms?